GLO1 and cardiovascular disorder: Even if the exact role of the glyoxalase system in cardiovascular disease has not been fully elucidated, it has been observed that in hemodialysis patients, the GLO1 A419C polymorphism is associated with a significantly higher prevalence of cardiovascular disease and peripheral vascular disease risk [59].